October 19th, 2023

Life Sciences BC seeks to raise the profile of our members and supporters, highlight their achievements, and promote BC's dynamic life sciences ecosystem. If you have news or a story to share, let us know. You can find previous editions of BioLinks newsletters and other resources on our website at News/Publications.

Dr. Hossein Kazemian, one of our event speakers, treated us to a fascinating tour of the Northern Analytical Lab Services at UNBC, which serves as Northern BC's hub for environmental and climate solutions innovation. Afterward, Richard McAloney, Director of the Centre for Technology Adoption for Aging in the North, also provided an insightful tour.

The Showcase event featured updates from Dr. Marcelo Bravo of Northern Health and the BC SUPPORT Unit Northern Centre; Dr. Hossein Kazemian of the Northern Analytical Laboratory Services at UNBC; Catherine St. George of Northern Health; and Dr. David Llewellyn of STEMCELL Technologies; with remarks from Roger Francis of Michael Smith Health Research BC.

Before returning home, we took the opportunity to visit with representatives from Northen Health, including Fraser Bell, event speaker Catherine St. George and Celia Belamour. We thank all the participants and our generous supporters, Michael Smith Health Research BC and UNBC, for making this event a success!

This Small Business Week, we celebrate our members who embody the resilient entrepreneurial spirit that drives our economy and contributes to global health. Small businesses make up 98% of all businesses in our province, and roughly one in 10 British Columbians are small business owners or entrepreneurs. In 2022, small businesses contributed 34% to BC's GDP - the highest in Canada!

Small and medium-sized businesses play a significant role in Canada's exports, and Canada's Trade Commissioner Service is a valuable resource for businesses seeking to expand internationally. Learn more about how the TCS helps businesses go global here.

This week, Canada’s Minister of Small Business announced an investment of up to $25M in five venture capital fund managers to promote diversity, equity, and inclusion within the Canadian VC ecosystem. Canada has also announced over $3M in funding for four BC-based projects, including two Small Business BC initiatives, that will support small and medium-sized businesses and help workers improve their technical skills. Learn more.

Additionally, the Minister issued a statement highlighting government support for Canadian enterprises, including flexible loan repayments, reduced tax rates and transaction fees, and investments in EDI entrepreneurship programs. You can explore expanded lending opportunities with the Canada Small Business Financing Program here.

Finally, check out the statement on Small Business Week by BC's Ministry of Jobs, Economic Development and Innovation here.

For businesses seeking to bolster their IP strategy to attract investment and enhance global competitiveness, the newly launched AccelerateIP program is a valuable resource.

Led by New Ventures BC in partnership with Innovate BC and supported by a network of accelerators, incubators, and tech organizations, including LSBC, this initiative draws its inspiration from the federal ElevateIP program by Innovation, Science and Economic Development Canada (ISED).

The program will remain active until March 31, 2026. Stay tuned for more information and updates!

Member Highlights 

BioTalent Canada is one of the nine non-profit organizations receiving $10.68M in funding through the third phase of Canada's Digital Skills for Youth (DS4Y) program. This program is a part of the government's Youth Employment and Skills Strategy (YESS), which provides Canadian youth with the necessary tools and experiences to kickstart their careers. Learn more.

Mai Yamamoto of Molecular You was recently featured in The Journal of Health, discussing how molecular blood analysis presents a comprehensive approach to assessing one's overall health. Read it here. Additionally, Molecular You's CEO, Jim Kean, was a guest on the eHealth Radio podcast, where he discussed how its AI-powered technology enables early detection of serious health conditions even before the onset of symptoms. Listen here.

Jill Tipping, CEO of BC Tech, authored the recent BIV News article “Scaling up B.C.’s clean industrial future with technology.” Read it here. 

Industry Highlights

Canada has launched a consultative process to gather Canadians’ thoughts on generative AI tools and the implications for copyright holders to consent and receive credit and compensation for using their works. This includes a series of stakeholder roundtables and an online survey for Canadians, available until Dec. 4. Learn more.

The National Research Council of Canada has released its latest annual report, “Laying the foundations for tomorrow’s innovations,” which focuses on taking research to the next level. Read it here. 

Kudos

Congratulations to Genome BC for receiving two Signal Awards for its "Nice Genes" podcast, for exceptional editing, and in the Science & Education category. Well done!

People on the Move

Peter Moreland-Giraldeau has been appointed to the Patented Medicine Prices Review Board (PMPRB) for a five-year term.

NervGen Pharma has announced the appointment of John Ruffolo, Founder and Managing Partner of Maverix Private Equity, to its Board of Directors.

David Kroeger has been appointed to Associate Director of Business Development at Zymeworks.

Genome Canada welcomes Dr. Ingrid Richter and Dr. Avak Kahvejian to its Board of Directors and Dr. Sohrab Shah to its Science and Industry Advisory Committee. Learn more.

The Health Research Foundation welcomes Frank Stramaglia, General Manager at Astellas Pharma, as its new Board Vice Chair.

GlycoNet welcomes Drs. Obadiah Plante, Antonia Borovina, Rika Jolie, and Hamed Ghanei to its Board of Directors. Learn more.

Applications Open

RBCx joins Hackergal to introduce iys Hackergal x RBCx Innovation Scholarship, supporting young girls and gender-diverse learners to become STEAM leaders. Each recipient will be awarded $5,000. Applications are due Nov. 20. Learn more.

Graduate students or postdoctoral fellows involved in aging research are encouraged to apply for the CIHR-IA Summer Program in Aging competition. Successful candidates will meet in Vancouver to discuss Ageism in Research, Delivery and Health Outcomes in Older Adults. Applications are due Dec. 7. Learn more.

Nominations are open for the 2023 VIATEC Community Awards, recognizing notable companies and individuals within Victoria’s $4B tech sector. Nominations are due Oct. 27. Learn more.

We invite you to explore our expanded list of current life sciences application opportunities by clicking on the following link: Applications Open.

#ICYMI

The Last Word

Last week, we had the pleasure of hosting an engaging conversation on the convergence of life sciences and artificial intelligence in BC’s life Sciences sector. 

We were joined by Jeff Guiler, Jennifer Chan, Marie-Noelle Lincourt-Ethier, and Marwan Akar of Merck Canada, and local AI leaders Handol Kim of Variational AI and George Hennen and Kenneth To of ViewsML Technologies. We are privileged to help enable these collaborative discussions that unite our sector!

Until next week,

Wendy and the LSBC team

Sumitomo Pharma and Pfizer in Canada Receive Health Canada Approval for MYFEMBREE®

Sumitomo Pharma Canada, Inc. and Pfizer Canada announced that Health Canada has granted a Notice of Compliance (NOC) for MYFEMBREE (Relugolix, estradiol and norethindrone acetate tablets) for the management of moderate to severe pain associated with endometriosis in pre-menopausal women on October 17, 2023... READ MORE

Evonik Launches Eudracap® Preclinic Functional Oral Capsule for Preclinical Trials

Evonik is launching a functional, ready-to-fill oral capsule designed for use in preclinical trials. EUDRACAP® preclinic enteric is a very small size 9h (5.1 mm), technical-grade capsule suitable for passing through the gastrointestinal tract of preclinical animal models. The enteric-coated capsule enables pharmaceutical companies to optimize drug development by reducing cost, time, and variables during preclinical trials. Companies can also move seamlessly from preclinical to clinical and commercial stages using the EUDRACAP® platform... READ MORE

WELL Health Launches ‘WELL AI Decision Support’ Powered by HEALWELL AI; Empowering Healthcare Providers with Next Generation Decision Support Systems

WELL Health Technologies Corp. a digital health company focused on tech-enabling healthcare providers, and its investee company, HEALWELL AI, are pleased to announce the launch of “WELL AI Decision Support”, a groundbreaking new service for healthcare providers. This partnership is the first major collaborative initiative between the two companies since the announcement of the Strategic Alliance Agreement on October 3, 2023... READ MORE

AbbVie’s RINVOQ® (upadacitinib) Receives Health Canada Approval as the First and Only Oral Therapy for the Treatment of Adults with Moderately to Severely Active Crohn’s Disease

AbbVie, announced that Health Canada has approved RINVOQ® (upadacitinib, 45 mg [induction dose] and 15 mg and 30 mg [maintenance dose]), an oral, once-daily selective and reversible JAK inhibitor, for the treatment of adults with moderately to severely active Crohn’s disease. Crohn’s disease is a chronic, systemic disease that manifests as inflammation within the gastrointestinal (digestive) tract, causing persistent diarrhea and abdominal pain. It is a progressive disease, meaning it gets worse over time in a substantial proportion of patients or may develop complications that require urgent medical care, including surgery... READ MORE

Aspect Biosystems Wins Twice at Technology Impact Awards

After winning “Most Promising Startup” in 2016, Aspect wins “Company of the Year – Scale” and “Gamechanger – Ambition” in 2023. On September 29, 2023, the technology industry in our home province of British Columbia came together to celebrate the 30th Anniversary of the Technology Impact Awards (TIAs), presented by BC Tech. Aspect Biosystems was a finalist in two categories, and we are immensely grateful to have won both: “Company of the Year – Scale” and “Gamechanger – Ambition.”... READ MORE

New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence

​Bausch Health Companies Inc. and its gastroenterology business, Salix Pharmaceuticals, announced findings from a retrospective database analysis of adjudicated claims data that examined the impact of access barriers for commercially-insured adults prescribed Xifaxan® (rifaximin) for reduction in risk of overt hepatic encephalopathy (OHE) recurrence in adults. Results suggest potentially critical treatment gaps due to access barriers, which may result in increased rates of OHE-related hospitalizations... READ MORE

Glyconet Welcomes Four New Members to the Board of Directors

GlycoNet is pleased to announce four new members have joined its Board of Directors: Dr. Obadiah Plante, Dr. Antonia Borovina, Dr. Rika Jolie and Dr. Hamed Ghanei. As members of the Board, they will be responsible for the overall stewardship of GlycoNet, including strategic planning and board governance... READ MORE

BC Groups Advance Patient Leadership in Health Research

At the CHILD-BRIGHT Network, youth with brain-based disabilities between the ages of 16-29 form a National Youth Advisory Panel. They inform the work of the network and provide consultation services to childhood disability researchers across Canada. Image used with permission from: CHILD-BRIGHT Network... READ MORE

NervGen Pharma Appoints John Ruffolo To Board Of Directors

NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced the appointment of John Ruffolo, Founder and Managing Partner of Maverix Private Equity to the Company’s Board of Directors... READ MORE

Omega Laboratories Achieves SAMHSA Accreditation

Omega Laboratories, Inc., a leading provider of comprehensive drug testing solutions, announces that its state-of-the-art laboratory in Ontario, Canada has received Substance Abuse and Mental Health Services Administration (SAMHSA) accreditation from the National Laboratory Certification Program (NLCP). This prestigious accreditation solidifies Omega’s commitment to quality, accuracy, and integrity in drug testing while providing another example of how Omega continues to evolve in order to better serve our clients... READ MORE

New Canadian Guideline for Treating High-Risk Drinking, Alcohol Use Disorder

The first-ever Canadian guideline for treating high-risk drinking and alcohol use disorder has been published by the BC Centre on Substance Use (BCCSU), a UBC Faculty of Medicine research center housed within Providence Health Care and Providence Research. Developed in partnership with the Canadian Research Initiative on Substance Misuse (CRISM), the guideline provides 15 evidence-based recommendations to reduce harms associated with high-risk drinking and to support people’s treatment and recovery from AUD... READ MORE

Health Canada Grants Market Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 2 To 5 Years With At Least One F508del Mutation

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that Health Canada has granted Market Authorization for the expanded use of PrTRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis (CF) ages 2 to 5 years who have at least one copy of the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. TRIKAFTA® was previously approved by Health Canada for use in people with CF 6 years and older with at least one F508del mutation... READ MORE

Pfizer Canada Invests in Canadian Innovation, Announcing Winners of Open Call for Healthcare Solutions

Pfizer Canada ULC, in partnership with Communitech, announces the tech and innovation startups selected from its open call to help address key challenges in Canadian healthcare, with the goal of enhancing outcomes and the patient experience. The initiative is driven by Pfizer Canada’s Healthcare Hub, a commitment to fostering innovation in the life sciences sector in Canada... READ MORE

Seagen to Highlight Overall Survival Data for PADCEV® and TIVDAK® during Presidential Symposium at ESMO Congress 2023

Seagen Inc. (Nasdaq: SGEN) announced the upcoming presentation of detailed results from two pivotal Phase 3 studies at the ESMO Congress 2023. Results from the EV-302 study of PADCEV (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) in locally advanced or metastatic urothelial cancer (la/mUC) in the first-line setting will be presented during a Presidential Symposium at the Congress... READ MORE

Aurinia Pharmaceuticals Announces Presentations at American Society of Nephrology (ASN) Kidney Week 2023 and 2023 American College of Rheumatology Convergence (ACR)

Aurinia Pharmaceuticals Inc., a biopharmaceutical company committed to delivering therapeutics that change the trajectory of autoimmune disease, today announced that data from 14 studies of LUPKYNIS® (voclosporin) will be presented at the American Society of Nephrology (ASN) Kidney Week 2023, taking place November 2-5 in Philadelphia, Pennsylvania and at the 2023 American College of Rheumatology Convergence (ACR), taking place November 10-15 in San Diego, California... READ MORE

Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio’s BARDA Award

Genevant Sciences, a leading nucleic acid delivery company with world- class platforms and a robust and expansive lipid nanoparticle (LNP) patent portfolio, announced the use of its LNP technology in Gritstone bio’s (Nasdaq: GRTS) self-amplifying mRNA (samRNA) vaccine candidate against COVID-19 in its CORAL program... READ MORE

Evotec and Amplitude Ventures Launch Partnership for Pre-Amp

Evotec SE announced a translational BRIDGE partnership with Pre-Amp, a new venture studio created by Amplitude Ventures, a full-stack venture capital firm focused on investing in precision medicine at the intersection of biology and machine learning. Pre-Amp unlocks new capabilities for Amplitude’s company creation activities. With over $ 500 m of assets under management across three managed funds, Amplitude has the financial resources to accelerate the creation and launch of high-impact companies... READ MORE

ScopeSys is commercializing a new single-molecule imaging technology called Convex Lens-induced Confinement (CLiC). This technique offers unprecedented capabilities for measuring individual molecular interactions in their native, solvated environment over long times and with high throughput.

Our assays are focused on two areas related to the development of new biological therapeutics: single-molecule measurement of oligonucleotide binding kinetics to RNA and DNA targets, and nanoparticle analytics for drug delivery applications. Our technology offers the ability to track multiple molecules to sequence the mechanism of complex reactions, as well as the ability to measure both size and loading of individual nanoparticles to characterize drug uptake and release over time. LEARN MORE

Government of Canada Invests Over $3 Million to Grow British Columbian Businesses and Build a Skilled Workforce

British Columbia’s small businesses are the heart of our communities and the economic engine of our province. To continue fueling the entrepreneurial spirit of British Columbians, the Government of Canada is making investments in organizations that help businesses grow... READ MORE

Government of Canada Helping Youth Acquire the Skills They Need to Thrive in the Evolving Digital Economy

Canada continues its efforts to build a strong, skilled workforce capable of adapting to the changing way we work and do business. Investing in Canadian youth is an essential part of the Government of Canada’s efforts to support an increasingly digital economy and prepare workers for new jobs in emerging industries. That is why the government is helping youth develop the skills and gain the experience they need to successfully transition into the labour market... READ MORE

Government of Canada Announces New Appointment to the Patented Medicine Prices Review Board

The Government of Canada is committed to appointing highly qualified candidates to best serve the interests of Canadians and is committed to open, transparent and merit-based processes for selecting Governor in Council appointees. Appointees play a fundamental role in Canadian democracy as they serve on commissions, boards, Crown corporations, agencies and tribunals across the country... READ MORE

Government of Canada Launches Consultation on the Implications of Generative Artificial Intelligence for Copyright

The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, and the Honourable Pascale St-Onge, Minister of Canadian Heritage, launched a consultation to gather Canadians’ thoughts on generative AI tools and the implications for copyright holders to give consent and receive credit and compensation for the use of their works... READ MORE

Minister Valdez Announces New Investments to Help Diverse Entrepreneurs Grow Their Businesses

Investments and access to capital are key to growing and supporting small and medium-sized enterprises (SMEs) with high-growth potential. This is especially true for entrepreneurs who have traditionally been under-represented in the venture capital (VC) space, including women and members of Indigenous, Black and 2SLGBTQI+ communities. When we support our small businesses, we’re supporting a strong economy that will help create good middle-class jobs for Canadians... READ MORE

Mitacs Post-Doc

A postdoctoral position is available in the laboratory of Prof. Filip Van Petegem at the University of British Columbia. The goal is to apply state of the art computational protein design methods to create novel protein molecules to enable structural cryo-EM characterization of therapeutic candidates and their target. The project is a collaboration with Amgen, one of the world’s leading biotechnology companies, and is supported through a MITACS scholarship...LEARN MORE

Scientist, Clinical Pharmacokinetics

This role represents Clinical Pharmacology in multi-functional teams supporting late-stage discovery programs. It involves analyzing clinical PK data, assisting in study design, maintaining knowledge of drug development approaches, and contributing to regulatory and scientific documentation. The position also requires building client relationships, summarizing and presenting results, and coordinating with SAS programmers and Clinical Operations for efficient deliverables...LEARN MORE

Associate Scientist, In Vivo Pharmacology

This role involves overseeing in vivo immuno-oncology experiments, managing internal and external studies, and providing hands-on support for mouse handling and administrative tasks. It also encompasses pharmacodynamic evaluations, technology exploration, mentorship, result presentation, and ensuring compliance with scientific standards and regulations while promoting collaboration...LEARN MORE

Research Associate I, Analytics

The role involves conducting experiments, providing research support, and performing antibody/antigen purification through chromatography techniques. Additionally, it includes supporting protein characterizations, maintaining scientific standards, and fostering collaborative working relationships within the organization while adhering to safety regulations and documentation procedures. The position also entails maintaining a safe and organized laboratory environment and ensuring the procurement and organization of reagents and chemicals for the Analytics team...LEARN MORE

Quality System Specialist

To succeed in this role, the applicant must be a strong Quality partner/ collaborator to drive operational efficiencies to achieve sustainable quality compliance and meet the business objectives of the site. Build strong relationships with the Quality team, internal stakeholders (such as Development & Formulation, Supply Chain, Project Management, etc.) and external suppliers to assure on-time delivery of products/ materials/ services that are quality compliant and fit for its intended purpose...LEARN MORE

Research Associate-Protein Biochemistry

Abdera Therapeutics is seeking a highly motivated and skilled Research Associate in antibody discovery programs. This position will provide an exciting and dynamic opportunity to positively contribute to research programs developing next-generation targeted radiopharmaceutical therapies...LEARN MORE

Senior Scientist Biologics

Abdera Therapeutics is seeking a highly motivated and skilled Senior Scientist in antibody discovery programs with a proven track record of research accomplishments. This position will provide an exciting and dynamic opportunity to positively contribute to research programs developing next-generation targeted radiopharmaceutical therapies...LEARN MORE

Research Associate II, Analytics

The candidate should have expertise in high-performance liquid chromatography (HPLC), mass spectrometry, and protein biochemistry for protein characterization. Experience with various extraction techniques, Agilent™ or Waters™ HPLC and mass spectrometry equipment, AKTA™ purification systems, biological matrices like plasma and serum, and Orbitrap™ mass spectrometry instrumentation would be advantageous. General knowledge of antibody and antibody drug conjugate structure/function is also considered a valuable asset...LEARN MORE

Animal Research Associate II

This role involves applying preclinical mouse pharmacology models for cancer therapy research. Responsibilities include handling mice for various procedures, preparing drugs using sterile techniques, managing human immune cell injections, coordinating sample handling, maintaining records, and ensuring adherence to scientific standards and regulations. Effective organization, teamwork, and adherence to established protocols are essential, while fostering collaborative relationships with colleagues and management is encouraged...LEARN MORE

Senior Research Associate I, In Vitro Pharmacology

This position involves planning and executing advanced experiments, troubleshooting methods, and independently analyzing and interpreting data. The role includes designing animal studies, contributing to project planning and coordination, staying updated on relevant scientific literature, maintaining inventory databases, and potentially training junior staff. The candidate is expected to adhere to scientific standards, safety regulations, and lab protocols while actively contributing to collaborative work environments and potentially co-authoring scientific papers...LEARN MORE

Scientist, DMPK/ADME

If you are selected for this position, you will be lead oversight of contract research partners and in-house development of in vitro DMPK assays, contributing to their optimization and methodology enhancement. Independently design experiments for assessing pharmacokinetics and pharmacodynamics of small molecules and ADCs, establishing in vitro to in vivo correlations, and collaborating across disciplines to advance drug development programs. Maintain up-to-date knowledge in drug metabolism and pharmacokinetics, adhere to data generation protocols, and foster collaborative relationships with colleagues and management...LEARN MORE

Associate Scientist, In Vivo Pharmacology

The ideal candidate should have expertise in xenograft, syngeneic, or humanized mouse tumor models (PBMC/CD34) and a strong grasp of immune cell function. Proficiency in animal handling, dosing, and sample collection, especially tail vein injections, is essential. They should also demonstrate knowledge of in vivo cancer models, antibody-based therapeutics, immune cell isolation, strong organizational skills, experience with contract research organizations, and effective teamwork within scientific project teams...LEARN MORE

Controller

The Employee will carry out standard job responsibilities and any additional tasks assigned by the Company, including financial management, policy enforcement, budgeting, tax coordination, audit oversight, control maintenance, reporting enhancement, compliance support, variance analysis, insurance management, stock options, governance assistance, benefits administration, and other duties as directed by the CFO and Executives...LEARN MORE

Quality Assurance Specialist

Filament Health is looking for an enthusiastic individual with a keen eye for detail to fill the role of Quality Assurance Specialist with experience in the pharmaceutical industry. Reporting to the Quality Director, the ideal candidate will be a self-starter who needs minimal oversight and thrives in a dynamic work environment. They will provide quality support to ensure adherence to Good Documentation and Production Practices, Health Canada regulations as well as international jurisdictions such as the US, EU, UK and Australia...LEARN MORE

Project Coordinator, Research and Innovation (R&I)

As the Project Manager for Research and Innovation (R&I) Agrifood and Natural Resources (ANR), you will primarily provide project management and administrative support to the R&I Senior Manager, ANR. Additionally, you will informally report to the Director of Operations to ensure alignment with processes and effective reporting of any issues that may arise during project management...LEARN MORE

Events Specialist (Co-op Student)

Life Sciences BC is looking for an enthusiastic new co-op student to assist with

preparations and execution of both in-person and virtual events. With several scheduled events happening between January and April, this role will offer a varied mix of tasks and projects and will provide fantastic experience for the chosen candidate to see how a professional industry association operates. This position will report to the Manager, Events...LEARN MORE

Partnerships & Memberships Specialist (Co-op Student)

Life Sciences BC is looking for an enthusiastic new co-op student to help maximize potential revenue opportunities and lead generation throughout the term. This role will offer a varied mix of tasks and projects and will provide fantastic experience for the chosen candidate to see how a professional industry association operates. This position will report to the Manager, Partnerships and Memberships...LEARN MORE

Marketing & Communications Specialist (Co-op Student)

In this limited-term role, you'll work alongside our Marketing and Communications Manager, contributing your skills to the planning and execution of diverse marketing and communications initiatives. This is an exceptional chance to acquire practical expertise while leaving your mark on both the life sciences field and the world of marketing and communications...LEARN MORE

The Netherlands Foreign Investment Agency (NFIA), an operational unit of the Dutch Ministry of Economic Affairs and Climate Policy, is your advisor for establishing and expanding your business in the Netherlands.

Together with our regional partners in the Invest in Holland network, the NFIA provides free and confidential information and services to help you with your business case for the Netherlands. We can guide you in your location search by providing independent services and connections that fit your company.

To start a conversation about doing business in the Netherlands, visit InvestinHolland.com or contact NFIA Canada director Andrew Dasselaar at andrew@nfia.com. LEARN MORE

BD Biosciences is pleased to be a member of LSBC. BD has been providing life science solutions for over 45 years, from specimen collection to cell analysis and sorting by flow cytometry. As research demands evolve and you seek to answer deeper biological questions, we continue to develop tools to support scientific discovery. Analyze cellular mRNA transcript and protein expression levels simultaneously across hundreds of thousands of cells with our comprehensive single-cell workflow. Resolve rare cell populations using our new Real Blue and Real Yellow fluorochromes conjugated to our extensive array of human and mouse antibody clones. Please visit the BD Bioscience booth to learn about our PRIMER program, offering you expert level support to develop multicolour flow cytometry panels for conventional and spectral instruments. LEARN MORE

Stay current by subscribing to this and our events newsletter!

Follow LSBC on Social Media!